The pivotal trial will evaluate the efficacy of the closed-loop insulin device in maintaining optimal blood glucose levels in ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Medtronic announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Royal Philips (PHG) and Medtronic Neurovascular announced a strategic advocacy partnership. As leaders in stroke diagnosis and treatment, the ...

Investor expectations for medical device makers have risen in recent quarters as demand for surgical procedures, especially ...

Medtronic has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to ...

Both companies also join the newly established World Stroke Organization Advocacy Coalition Amsterdam, the Netherlands - Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, and ...